Chugh Y, Dhiman RK, Premkumar M, Prinja S, Singh Grover G, Bahuguna P.
Real-world cost-effectiveness of pan-genotypic Sofosbuvir-Velpatasvir combination versus genotype dependent directly acting anti-viral drugs for treatment of hepatitis C patients in the universal coverage scheme of Punjab state in India.
PLoS One 2019;
14 (08) e0221769
Download Bibliographical Data